Update: Executive Officer Notice: Funding of Glatect®/Copaxone®/Glatiramer Acetate Injection under the Ontario Drug Benefit Program

Ontario Public Drug Programs notice (PDF) for pharmacies and dispensers.

ScopeUp collects Ontario and national pharmacy practice updates and links every item to its source. Verify details against the source document before changing workflows.